Results 171 to 180 of about 1,414 (186)

Real-world outcomes of two-year Conbercept therapy for diabetic macular edema

International Journal of Ophthalmology, 2021
Ming-Wei Zhao
exaly  

Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy

Journal of Ocular Pharmacology and Therapeutics, 2020
Shen Xi, Zhongjing Lin, Jili Chen
exaly  

Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis

International Journal of Clinical Pharmacy, 2023
Pan Hu
exaly  

One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema

Current Eye Research, 2018
Wanzhen Jiao, Bojun Zhao
exaly  

One-year results of intravitreal conbercept in treatment-naïve subjects with polypoidal choroidal vasculopathy

Graefe's Archive for Clinical and Experimental Ophthalmology, 2020
Xiaoxin Li, Ian Y Wong, Ming-Wei Zhao
exaly  

Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress

Life Sciences, 2021
exaly  

Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy

Journal of Ocular Pharmacology and Therapeutics, 2019
Zhang Han
exaly  

Aflibercept/Conbercept/Dexamethasone

Reactions Weekly
openaire   +1 more source

Aflibercept/Conbercept/Ranibizumab

Reactions Weekly
openaire   +1 more source

Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion

Current Eye Research, 2017
Bojun Zhao
exaly